自身免疫性肝炎临床治疗进展. (Chinese)

Autoimmune hepatitis (AIH) is an autoimmune-mediated chronic progressive liver inflammatory disease with unknown pathogenesis. The main purpose of AIH treatment at present is to relieve symptoms, improve liver function and pathological abnormalities, and slow down the progression to liver fibrosis. Easy recurrence and a large difference in prognosis bring difficulties to the treatment of this disease. In recent years, AIH treatment methods mainly include standard immunosuppressive therapy, substitutive therapy or second-line therapy for ineffective standard therapy, traditional Chinese medicine treatment with reduced side effects, and liver transplantation rescue therapy for end-stage AIH or severe fulminant AIH. This article reviews the above treatment methods for AIH, in order to provide a reference for clinical application. [ABSTRACT FROM AUTHOR]

自身免疫性肝炎（AIH）是一种发病原因不明的由自身免疫介导的慢性进行性肝脏炎症性疾病。目前治疗AIH的主要目的是缓解症状，改善肝功能及病理组织异常，减慢向肝纤维化的进展。由于其容易复发，预后差异大，给治疗带来难度。近年来，AIH治疗方法主要有标准免疫抑制疗法，标准治疗无效的替代疗法或二线疗法，减轻副作用的中医药疗法，以及AIH末期或严重暴发性AIH的肝移植抢救疗法。对上述AIH治疗方法进行了系统综述，以期为临床应用提供参考。 [ABSTRACT FROM AUTHOR]

Copyright of Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi is the property of Journal of Clinical Hepatology and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)